24 September 2020
We have an update on Boltz. His Blastomycosis test came back negative. Based on all the other results, the Veterinarians have narrowed down the list to two likely diagnosis. The first is Degenerative myelopathy (DM). It is a genetic neurologic disorder with symptoms of loss of coordination and decreased muscle strength typically beginning in the hind limbs. Canine Degenerative Myelopathy (DM) is a progressive disease of the spinal cord and ultimately the brainstem and cranial nerves. While there is no definitive test for DM, there is new research that has determined a gene associated with a risk factor for that disease. We are working with our Veterinarians to submit a blood sample for a DNA test to see if Boltz possesses this mutated gene.
While DM is not considered a painful disease, wolf care staff will definitely assess quality of life parameters to ensure Boltz’s physical and psychological needs are met. As you can see in the photo posted this week, he is resting comfortably in the Pack Holding area. One of our health assessments is the clarity of an animals eyes, and in this photo, he appears very alert and clear. He is continuing a dose of prednisone as an anti-inflammatory medication, but we are transitioning down to a maintenance dose always mindful of the effectiveness of prescription meds versus the risk of long-term use.
Another remote diagnosis is a round cell tumor, which can present itself in a variety of ways. Boltz’s recent MRI didn’t reveal any visible tumors of the spine or the brain that may contribute to his neurological symptoms, but we will continue to monitor bloodwork to assess any increase in white cell counts. Thank you to all that have inquired about his condition and donated to his fundraiser. We are still accepting donations to assist with the many tests that were conducted, his ongoing medical care, adjustments and staffing to keep him and Grizzer comfortable in retirement. Follow this link to donate https://www.facebook.com/donate/363942581650869/
